论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
泌尿系恶性肿瘤放疗和免疫疗法的联合治疗:当前证据和临床考虑
Authors Lei H, Shi M, Xu H, Bai S, Xiong X, Wei Q, Yang L
Received 23 October 2020
Accepted for publication 23 January 2021
Published 24 February 2021 Volume 2021:13 Pages 1719—1731
DOI https://doi.org/10.2147/CMAR.S288337
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Chien-Feng Li
Abstract: Although it has always been believed that radiation has immunosuppressive effects, more and more preclinical and clinical trials have shown that the combination of radiotherapy and immunotherapy has a potential synergistic effect to treat cancers including urological malignancies. When radiotherapy is combined with immunotherapy, improved prognosis has been observed in different urinary tumors. However, there is no standard treatment, such as the optimal dose/fractionation and the sequence of immunotherapy and radiotherapy. In this review, we discussed the effects of radiotherapy on the cancer immune system and emphasized the synergy of radiotherapy combined with immunotherapy. Although it has significantly improved the prognosis of tumors, there are still some unresolved questions about how to best use this combination in clinical practice. Ongoing trials will provide further information on the interaction of radiotherapy combined with immunotherapy, and are expected to guide clinical practice and improve clinical outcomes.
Keywords: radiotherapy, immunotherapy, urological malignancies, abscopal effect